HIV Seropositivity [clinicaltrials_resource:36d2365f0548abfd8457f4eef31d569d]
Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma [clinicaltrials:NCT00006171]Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART [clinicaltrials:NCT00035581]The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART [clinicaltrials:NCT00035893]clinicaltrials:NCT00130819A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent. [clinicaltrials:NCT00381212]clinicaltrials:NCT00721305Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus [clinicaltrials:NCT00797030]Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+ [clinicaltrials:NCT01174914]An Evaluation of a Rapid Test for HIV [clinicaltrials:NCT01733927]Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center [clinicaltrials:NCT01881971]Revealing Increased Axonal Loss in Treated HIV Patients [clinicaltrials:NCT02003989]Prevalence of Cerebral Small Vessel Disease in HIV Infected Patients [clinicaltrials:NCT02082574]Assessment of Age-related Hearing Loss in HIV-1 Patients [clinicaltrials:NCT02154971]Effects of VSL#3 on Neuro-cognitive Profile of HIV Patients [clinicaltrials:NCT02276326]
condition [clinicaltrials_vocabulary:condition]
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals [clinicaltrials:NCT00000633]A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals [clinicaltrials:NCT00000648]A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells [clinicaltrials:NCT00000667]Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients [clinicaltrials:NCT00001474]A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis [clinicaltrials:NCT00002321]Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma [clinicaltrials:NCT00006171]Measuring HIV Quality of Care [clinicaltrials:NCT00012701]Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART [clinicaltrials:NCT00035581]The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART [clinicaltrials:NCT00035893]Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS [clinicaltrials:NCT00106795]clinicaltrials:NCT00130819Safety and Acceptability of Carraguard® in HIV Positive Women and Men [clinicaltrials:NCT00213005]Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission [clinicaltrials:NCT00213083]Effects of Endocrine Health on Mental Performance of Men and Women Using Drugs [clinicaltrials:NCT00245531]Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia [clinicaltrials:NCT00270530]PTSD and Risk Behavior in HIV Positive Female Adolescents [clinicaltrials:NCT00271882]clinicaltrials:NCT00367458A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent. [clinicaltrials:NCT00381212]clinicaltrials:NCT00381303Enhancing Oral Health Care Use by HIV Positive Individuals [clinicaltrials:NCT00444977]Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users [clinicaltrials:NCT00447798]PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD) [clinicaltrials:NCT00459693]Motivation and Patch Treatment for HIV-Positive Smokers [clinicaltrials:NCT00551720]Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol [clinicaltrials:NCT00639145]Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis [clinicaltrials:NCT00659971]Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay [clinicaltrials:NCT00686205]clinicaltrials:NCT00721305Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults [clinicaltrials:NCT00741637]Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus [clinicaltrials:NCT00797030]The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment [clinicaltrials:NCT00857350]The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata [clinicaltrials:NCT00941889]Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy [clinicaltrials:NCT00959361]Profile of HIV Seropositive Patients [clinicaltrials:NCT00981279]Study of Vitamin D Supplementation to Male HIV Sero-positive Patients [clinicaltrials:NCT00990678]The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215 [clinicaltrials:NCT01034800]clinicaltrials:NCT01140880Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border [clinicaltrials:NCT01152684]Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes [clinicaltrials:NCT01154543]RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice [clinicaltrials:NCT01154556]Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+ [clinicaltrials:NCT01174914]
condition browse [clinicaltrials_vocabulary:condition-browse]
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals [clinicaltrials:NCT00000633]A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals [clinicaltrials:NCT00000648]A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells [clinicaltrials:NCT00000667]Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients [clinicaltrials:NCT00001474]A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis [clinicaltrials:NCT00002321]Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma [clinicaltrials:NCT00006171]Measuring HIV Quality of Care [clinicaltrials:NCT00012701]Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART [clinicaltrials:NCT00035581]The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART [clinicaltrials:NCT00035893]Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS [clinicaltrials:NCT00106795]clinicaltrials:NCT00130819Safety and Acceptability of Carraguard® in HIV Positive Women and Men [clinicaltrials:NCT00213005]Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission [clinicaltrials:NCT00213083]Effects of Endocrine Health on Mental Performance of Men and Women Using Drugs [clinicaltrials:NCT00245531]Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia [clinicaltrials:NCT00270530]PTSD and Risk Behavior in HIV Positive Female Adolescents [clinicaltrials:NCT00271882]clinicaltrials:NCT00367458A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent. [clinicaltrials:NCT00381212]clinicaltrials:NCT00381303Enhancing Oral Health Care Use by HIV Positive Individuals [clinicaltrials:NCT00444977]Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users [clinicaltrials:NCT00447798]PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD) [clinicaltrials:NCT00459693]Motivation and Patch Treatment for HIV-Positive Smokers [clinicaltrials:NCT00551720]Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol [clinicaltrials:NCT00639145]Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis [clinicaltrials:NCT00659971]Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay [clinicaltrials:NCT00686205]clinicaltrials:NCT00721305Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults [clinicaltrials:NCT00741637]Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus [clinicaltrials:NCT00797030]The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment [clinicaltrials:NCT00857350]The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata [clinicaltrials:NCT00941889]Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy [clinicaltrials:NCT00959361]Profile of HIV Seropositive Patients [clinicaltrials:NCT00981279]Study of Vitamin D Supplementation to Male HIV Sero-positive Patients [clinicaltrials:NCT00990678]The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215 [clinicaltrials:NCT01034800]clinicaltrials:NCT01140880Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border [clinicaltrials:NCT01152684]Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes [clinicaltrials:NCT01154543]RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice [clinicaltrials:NCT01154556]Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+ [clinicaltrials:NCT01174914]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
HIV Seropositivity [clinicaltrials_resource:36d2365f0548abfd8457f4eef31d569d]
Bio2RDF identifier
36d2365f0548abfd8457f4eef31d569d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:36d2365f0548abfd8457f4eef31d569d
identifier
clinicaltrials_resource:36d2365f0548abfd8457f4eef31d569d
title
HIV Seropositivity
@en
type
label
HIV Seropositivity [clinicaltrials_resource:36d2365f0548abfd8457f4eef31d569d]
@en
HIV Seropositivity